Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

nDatalyze advances YMI through a Marketing Contract

C.NDAT

(TheNewswire)

nDatalyze Corp.

Calgary, Alberta – TheNewswire - August 11, 2022nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) is pleased to announce that the Corporation has entered into a marketing contract with Venture Communications ("VenComm") to introduce YMI to the consumer mobile health ("mHealth") market beginning in the Fall, 2022.

"This multi-faceted contract involves a totally new user experience ("UX"), public relations, Social Media aspects including common platforms, influencers, brand ambassador(s)/spokesperson(s), print and electronic media, and overall marketing management. We have been working with VenComm for many months and are highly confident in the success of the plan they developed for YMI." said NDAT's President, Jim Durward.

The Corporation expects delivery of the new UX by the end of August, whereafter it will be integrated with the existing fully-functional machine-learning platform in advance of public release by October, 2022. Initial revenues are expected to commence by calendar year-end, 2022. The VenComm marketing contract is fully-funded by the Corporation's cash position of approximately $1.2 million.

About nDatalyze Corp.:

nDatalyze Corp. generates technology-based, health-related solutions. The YMI division is developing a machine-learning based, online consumer mental health application with it's database licensing division focusing on providing a specialized health-related Reference Database to application developers and researchers. Analytical reports derived from the YMI system are based on the Corporation's proprietary Reference Database consisting of >1200 biometric records complete with associated electroencephalogram ("EEG") data. With installations worldwide, it's MedXtractor division manufactures small-scale bio-extractors that are used to extract compounds from a variety of botanical biomasses. Investors are advised that YMI is in the development stage and accordingly any forward looking statements are subject to risks and uncertainties that are beyond the control of the Corporation.

FOR FURTHER INFORMATION, PLEASE CONTACT:

nDatalyze Corp.

James Durward, President and CEO

Telephone: (403) 689-3901

Email: jimd@ndatalyze.comWebsite: www.ndatalyze.com

Investor Relations

RBMG - RB Milestone Group LLC

ndatalyze@rbmilestone.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

Copyright (c) 2022 TheNewswire - All rights reserved.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today